23andMe Wins FDA Approval for New Genetic Test »

In the past, the FDA has expressed worry that consumers might misinterpret at-home genetic tests, leading to improper decisions without physician guidance. This is why 23andMe was forced table one of their personal genome tests in November 2013. It's been an uphill battle, 23andMe's leaders say. That's also why, when the FDA granted direct-to-consumer marketing rights for 23andMe’s Bloom Syndrome…